immune checkpoint inhibitors

/Tag:immune checkpoint inhibitors

Abstract Number: 548

AN UNCANNY SWEET SIDE OF ATEZOLIZUMAB

Case Presentation: 90-year-old female presented with generalized weakness, nausea, vomiting, and diarrhea of 3 days duration. She also reported anorexia but denied any fever, chills, abdominal pain, chest pain, shortness of breath and cough. Vital [...]

By | 2019-03-11T14:29:14+00:00 March 11th, 2019|Adult, Clinical Vignettes, Hospital Medicine 2019|Comments Off on AN UNCANNY SWEET SIDE OF ATEZOLIZUMAB

HM2018 Abstract Number: 442

DIABETIC KETOACIDOSIS TRIGGERED BY PEMBROLIZUMAB IN A PATIENT WITH BLADDER CANCER

Case Presentation: We are presenting a case of a 71-year-old male patient with a history of hypertension, non-insulin dependent type 2 diabetes mellitus (DM) well controlled on metformin, and non-invasive high grade urothelial bladder cancer [...]

By | 2018-03-19T13:05:06+00:00 March 19th, 2018|Adult, Clinical Vignettes, Hospital Medicine 2018|Comments Off on DIABETIC KETOACIDOSIS TRIGGERED BY PEMBROLIZUMAB IN A PATIENT WITH BLADDER CANCER

HM2018 Abstract Number: 819

Immune checkpoint inhibitor-induced encephalitis: a case report

Case Presentation: A 77 year old man with stage IIIC mucosal melanoma, hypothyroidism, HTN and COPD presents from an outside hospital with two months of rapidly progressive altered mental status. He was diagnosed with melanoma [...]

By | 2018-03-19T12:57:52+00:00 March 19th, 2018|Adult, Clinical Vignettes, Hospital Medicine 2018|Comments Off on Immune checkpoint inhibitor-induced encephalitis: a case report